Baird Financial Group
ALT icon

Baird Financial Group’s Altimmune ALT Stock Holding History

Baird Financial Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$732K Buy
237,522
+118,082
+99% +$501K ﹤0.01% 1360
2025
Q4 		$431K Hold
119,440
– – ﹤0.01% 1526
2025
Q3 		$450K Buy
119,440
+60,000
+101% +$232K ﹤0.01% 1505
2025
Q2 		$230K Hold
59,440
– – ﹤0.01% 1668
2025
Q1 		$297K Hold
59,440
– – ﹤0.01% 1563
2024
Q4 		$429K Buy
+59,440
New +$454K ﹤0.01% 1433

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Baird Financial Group's ALT Position: Q1 2026 in Review

Baird Financial Group increased its Altimmune (ALT) stake by 99% in Q1 2026, buying an estimated $501K and bringing the position to 237,522 shares worth $732K. The position accounts for ﹤0.01% of the portfolio, ranked #1360.

Baird Financial Group first reported a position in ALT in Q4 2024 and has held it in 6 quarters since. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Baird Financial Group held 237,522 shares of Altimmune worth $732K as of Q1 2026.
  • Baird Financial Group bought 118,082 Altimmune shares in Q1 2026, an estimated $501K.
  • Altimmune made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1360 holding.
  • Baird Financial Group first reported a position in Altimmune in Q4 2024 and has held it in 6 quarters since.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.